论文部分内容阅读
目的:分析甘精胰岛素联合阿卡波糖治疗2型糖尿病的疗效,为临床提供参考。方法:选取我院收治的100例2型糖尿病患者作为观察对象,收治时间为2012年7月~2014年10月,采用随机分组的方式将100例2型糖尿病患者分成两组,实验组50例,对照组50例,对照组采取诺和灵30R进行治疗,实验组采取甘精胰岛素联合阿卡波糖进行治疗,观察比较两组2型糖尿病患者治疗后的空腹血糖、餐后2h血糖以及糖化血红蛋白水平。结果:两组2型糖尿病患者治疗后的空腹血糖、餐后2h血糖以及糖化血红蛋白水平的比较结果存在显著差异,P<0.05,差异有统计学意义。结论:对2型糖尿病患者采取甘精胰岛素联合阿卡波糖进行治疗,能够有效降低患者的空腹血糖、餐后2h血糖以及糖化血红蛋白水平,值得临床推广应用。
Objective: To analyze the efficacy of insulin glargine combined with acarbose in the treatment of type 2 diabetes mellitus (T2DM). Methods: A total of 100 type 2 diabetic patients treated in our hospital were selected as the observation subjects. The patients were admitted to our hospital from July 2012 to October 2014. 100 cases of type 2 diabetes mellitus were divided into two groups randomly. 50 cases in the experimental group , The control group of 50 cases, the control group took Novolin 30R for treatment, the experimental group with insulin glargine combined with acarbose treatment, observed two groups of type 2 diabetic patients after treatment of fasting blood glucose, 2h postprandial blood glucose and glycosylation Hemoglobin level. Results: There was a significant difference in fasting blood glucose, postprandial 2h blood glucose and glycosylated hemoglobin after treatment between two groups of type 2 diabetic patients, P <0.05, the difference was statistically significant. Conclusion: Treatment of patients with type 2 diabetes with insulin glargine and acarbose can effectively reduce fasting blood glucose, 2h postprandial blood glucose and glycosylated hemoglobin, which is worthy of clinical application.